|
JPMORGAN EUROPEAN GROWTH & INCOME PLC (the 'Company') |
|
|
Legal Entity Identifier: 549300D8SPJFHBDGXS57 |
|
|
THE COMPANY ANNOUNCES THE TEN LARGEST INVESTMENTS IN % OF TOTAL ASSETS As at: 31 October 2025 |
|
|
Asml |
4.2% |
|
Novartis |
3.3% |
|
Siemens |
2.9% |
|
Roche Holdings |
2.8% |
|
Sap |
2.8% |
|
Nestle |
2.6% |
|
JPMorgan European Discovery Trust Plc |
2.4% |
|
Safran Sa |
2.2% |
|
Unicredit SPA |
2.2% |
|
Allianz |
2.2% |
|
Total |
27.7% |
|
Excludes Investments in Liquidity stocks |
|
|
Name of contact and telephone number for queries: |
|
|
Paul Ainger 0044 207 742 6524 |
|
|
Name of authorised company official responsible for making this notification: |
|
|
Paul Winship 0044 207 742 9815 - Company Secretary |
|
|
Date: 13 November 2025 |
|
|
|
|